These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 37540398)

  • 1. The Potential of Psychedelics for the Treatment of Episodic Migraine.
    Schindler EAD
    Curr Pain Headache Rep; 2023 Sep; 27(9):489-495. PubMed ID: 37540398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelics as preventive treatment in headache and chronic pain disorders.
    Schindler EAD
    Neuropharmacology; 2022 Sep; 215():109166. PubMed ID: 35718005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychedelics in the Treatment of Headache and Chronic Pain Disorders.
    Schindler EAD
    Curr Top Behav Neurosci; 2022; 56():261-285. PubMed ID: 35546382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.
    Schindler EAD; Sewell RA; Gottschalk CH; Luddy C; Flynn LT; Lindsey H; Pittman BP; Cozzi NV; D'Souza DC
    Neurotherapeutics; 2021 Jan; 18(1):534-543. PubMed ID: 33184743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are psychedelics the answer to chronic pain: A review of current literature.
    Kooijman NI; Willegers T; Reuser A; Mulleners WM; Kramers C; Vissers KCP; van der Wal SEI
    Pain Pract; 2023 Apr; 23(4):447-458. PubMed ID: 36597700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychedelic drugs for psychiatric disorders.
    da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M
    J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Therapeutic Potential of Psilocybin.
    Lowe H; Toyang N; Steele B; Valentine H; Grant J; Ali A; Ngwa W; Gordon L
    Molecules; 2021 May; 26(10):. PubMed ID: 34063505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adapting psychedelic medicine for headache and chronic pain disorders.
    Schindler EAD; Hendricks PS
    Expert Rev Neurother; 2023; 23(10):867-882. PubMed ID: 37652000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The psychedelic effects of cannabis: A review of the literature.
    Wolinsky D; Barrett FS; Vandrey R
    J Psychopharmacol; 2024 Jan; 38(1):49-55. PubMed ID: 37947321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.
    Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychedelics and Psychedelic-Assisted Psychotherapy.
    Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM;
    Am J Psychiatry; 2020 May; 177(5):391-410. PubMed ID: 32098487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The varieties of psychedelic law.
    Marks M
    Neuropharmacology; 2023 Mar; 226():109399. PubMed ID: 36565855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.
    Schindler EAD; Sewell RA; Gottschalk CH; Luddy C; Flynn LT; Zhu Y; Lindsey H; Pittman BP; Cozzi NV; D'Souza DC
    Headache; 2022 Nov; 62(10):1383-1394. PubMed ID: 36416492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.
    Carhart-Harris RL; Goodwin GM
    Neuropsychopharmacology; 2017 Oct; 42(11):2105-2113. PubMed ID: 28443617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.
    Johnson MW
    Curr Top Behav Neurosci; 2022; 56():213-227. PubMed ID: 35704271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Majić T; Schmidt TT; Gallinat J
    J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.
    Schindler EAD; Sewell RA; Gottschalk CH; Flynn LT; Zhu Y; Pittman BP; Cozzi NV; D'Souza DC
    J Neurol Sci; 2024 May; 460():122993. PubMed ID: 38581739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compassionate use of psychedelics.
    Greif A; Šurkala M
    Med Health Care Philos; 2020 Sep; 23(3):485-496. PubMed ID: 32468195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Psychedelics in Treatment-Resistant Depression.
    Kamal S; Jha MK; Radhakrishnan R
    Psychiatr Clin North Am; 2023 Jun; 46(2):291-305. PubMed ID: 37149346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychedelic Psychiatry's Brave New World.
    Nutt D; Erritzoe D; Carhart-Harris R
    Cell; 2020 Apr; 181(1):24-28. PubMed ID: 32243793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.